Home Non-Invasive Positive Pressure Ventilation (NIPPV) Devices for Respiratory Insufficiency and Failure - (Effective Date - 2026-10-15) 1.01.57

By October 15, 2026: Billing team must implement prior authorization requirements and clinical documentation validation for all NIPPV device claims submitted to Excellus BlueCross BlueShield. (1) Update billing system to enforce policy statement criteria before claim submission: require documented evidence of FVC <80% predicted, MIP <60 cm H2O, oxygen desaturations ≤88%, or ABG PaCO2 ≥45 mm Hg for BPAP (E0470/E0471) claims on neuromuscular/thoracic cases; require all documented criteria met for non-invasive home mechanical ventilation (E0466) claims; establish condition-specific validation rules for hypoventilation syndrome, COPD CRF, and OSA diagnoses per Policy Statements IV-XII. (2) Providers and clinical staff must attach supporting diagnostic test results (spirometry, ABG, sleep studies, oximetry recordings) to all NIPPV authorization requests—claims lacking required clinical documentation will be denied. (3) Clinical documentation specialists should create checklist templates aligned to each diagnosis category to ensure providers document minimum recording times (2+ hours for sleep studies), FIO2 conditions during testing, and symptomatology per policy requirements. (4) Billing team should configure system alerts to flag claims for E0467/E0468 (dual/multifunction devices) to verify members have not previously received individual component devices (oxygen, cough, suction, nebulizer). Failure to comply with documentation and prior authorization requirements will result in automatic claim denials.